Amoxicillin (drug interactions)

DEFINITION: Relative of the antibiotic penicillin but modified to have a broader spectrum of effect.

INTERACTIONS: Bromelain, vitamin K, anticoagulants, allopurinol, and probenecid

TRADE NAMES: Amoxil, Trimox, Wymox

Bromelain

Effect: Possible helpful interaction

According to two studies, the supplement bromelain (from pineapple stems) may increase the absorption of amoxicillin. This effect might help the antibiotic work better.

Vitamin K

Effect: Possible nutritional depletion

There are concerns that antibiotic treatment might reduce levels of vitamin K in the body. However, this effect seems to be slight and only significant in persons who are already considerably deficient in vitamin K.

Anticoagulants

Effect: Increased risk of bleeding

Patients taking anticoagulants, or blood thinners, such as Warfarin may be at risk for bleeding if taken with amoxicillin. This is especially true in older patients or patients with liver or kidney diseases. Monitoring of international normalized ratios (INR) via blood work and dosage adjustment may be necessary.

Allopurinol and Probenecid

Effect: Increased risk of skin rash or hives

Patients with gout taking allopurinol or probenecid, both of which decrease uric acid in the body, may have an increased incidence of rash or hives when combining with amoxicillin than patients taking amoxicillin alone.

94415610-90147.jpg94415610-90148.jpg

Bibliography

Apa, Nicole. "7 Amoxicillin Interactions You Should Know About." Good Rx Health, 7 Oct. 2022, www.goodrx.com/amoxicillin/interactions. Accessed 8 Dec. 2022.

Akhavan, Bobak J., et al. “Amoxicillin.” National Library of Medicine, StatPearls, 17 Nov. 2023, www.ncbi.nlm.nih.gov/books/NBK482250/. Accessed 12 Sept. 2024.

Cohen, H., et al. “The Development of Hypoprothrombinaemia Following Antibiotic Therapy in Malnourished Patients with Low Serum Vitamin K1 Levels.”British Journal of Haematology68 (1988): 63-66.

Conly, J., and K. Stein. “Reduction of Vitamin K2 Concentrations in Human Liver Associated with the Use of Broad Spectrum Antimicrobials.” Clinical and Investigative Medicine 17 (1994): 531-539.

Goss, T. F., et al. “Prospective Evaluation of Risk Factors for Antibiotic-Associated Bleeding in Critically Ill Patients.” Pharmacotherapy 12 (1992): 283-291.

Shearer, M. J., et al. “Mechanism of Cephalosporin-Induced Hypoprothrombinemia: Relation to Cephalosporin Side Chain, Vitamin K Metabolism, and Vitamin K Status.” Journal of Clinical Pharmacology 28 (1988): 88-95.